DrugPatentWatch Database Preview
Biologic Drugs With Mechanism of Action: HER2/Neu/cerbB2 Antagonists
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Biologic Drugs With Mechanism of Action: HER2/Neu/cerbB2 Antagonists
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Genentech | HERCEPTIN | trastuzumab | VIAL; INTRAVENOUS | 103792 | 001 | 1998-09-25 | Start Trial | Novartis AG (Basel, CH) | 2039-02-26 | RX | Orphan | search |
Genentech | HERCEPTIN | trastuzumab | VIAL; INTRAVENOUS | 103792 | 001 | 1998-09-25 | Start Trial | Array BioPharma Inc. (Boulder, CO) | 2028-10-22 | RX | Orphan | search |
Genentech | HERCEPTIN | trastuzumab | VIAL; INTRAVENOUS | 103792 | 001 | 1998-09-25 | Start Trial | ACADEMIA SINICA (Taipei, TW) | 2034-05-27 | RX | Orphan | search |
Genentech | HERCEPTIN | trastuzumab | VIAL; INTRAVENOUS | 103792 | 001 | 1998-09-25 | Start Trial | XUANZHU PHARMA CO., LTD. (Jinan, Shandong Province, CN) | 2034-09-29 | RX | Orphan | search |
Genentech | HERCEPTIN | trastuzumab | VIAL; INTRAVENOUS | 103792 | 001 | 1998-09-25 | Start Trial | Yeda Research and Development Co. Ltd. (Rehovot, IL) | 2034-09-08 | RX | Orphan | search |
Genentech | HERCEPTIN | trastuzumab | VIAL; INTRAVENOUS | 103792 | 001 | 1998-09-25 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | Orphan | search |
Genentech | HERCEPTIN | trastuzumab | VIAL; INTRAVENOUS | 103792 | 001 | 1998-09-25 | Start Trial | OP NANO CO., LTD. (Taipei, TW) TRENDMED CO., LTD. (Beitou Dist., Taipei, TW) | 2039-02-26 | RX | Orphan | search |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |